JonesTrading Initiates Coverage On Oncolytics Biotech with Buy Rating, Announces Price Target of $9
Portfolio Pulse from richadhand@benzinga.com
JonesTrading analyst Soumit Roy initiates coverage on Oncolytics Biotech (NASDAQ:ONCY) with a Buy rating and announces a price target of $9.
May 24, 2023 | 8:46 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JonesTrading analyst Soumit Roy initiates coverage on Oncolytics Biotech with a Buy rating and a price target of $9.
The Buy rating and price target announcement by JonesTrading analyst Soumit Roy is a positive signal for Oncolytics Biotech. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100